| Patents for C07J 1 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 17 beta by a carbon atom, e.g. oestrane, androstane (4,828) |
|---|
| 03/05/2003 | EP1288220A2 Neuroactive 3.alpha.-hydroxy-steroids of the androstane and pregnane series |
| 03/05/2003 | EP1140972B1 New 7-alpha, 17-alpha-bis-alkylated testosterone derivatives and their use in long-term therapy of androgen-dependent diseases |
| 03/04/2003 | US6528676 Estrogenic compounds as anti-mitotic agents |
| 02/27/2003 | WO2003015792A1 Anti-tumour 2-alkoxyestradiol sulfamates |
| 02/27/2003 | WO2003015791A1 Phophylactic and therapeutic use of hydroxysteroids |
| 02/27/2003 | WO2003015751A1 Pharmaceutical composition for nasal delivery of estradiol and norethisterone |
| 02/27/2003 | WO2002058634A3 ESTRADIOL-16α-CARBOXYLIC ACID ESTERS AS LOCALLY ACTIVE ESTROGENS |
| 02/27/2003 | WO2001097860A3 Pharmaceuticals for the imaging of angiogenic disorders for use in combination therapy |
| 02/27/2003 | US20030039977 Carbamate-derivatized nucleosides and oligonucleosides |
| 02/27/2003 | CA2454671A1 Pharmaceutical composition for nasal delivery of estradiol and norethisterone |
| 02/26/2003 | EP1285969A2 Process for producing sterol or stanol esters by enzymatic transesterification in solvent and water-free media |
| 02/26/2003 | EP1285927A2 Use of glucocorticoid antagonists for the prevention and treatment of diseases of the male reproductive system |
| 02/25/2003 | US6525039 B-ring estratrienes |
| 02/25/2003 | CA2078804C Manufacture and use of novel glycosides of catechol estrogens |
| 02/20/2003 | WO2002072003A3 Use of steroid derivatives for the treatment of a benighn and/or malignant tumour |
| 02/20/2003 | US20030036540 Betulinol derivatives |
| 02/19/2003 | EP1284273A2 Estra-1,3,5(10)-trien-3-sulfamates a process for their production and pharmaceutical compositions containing them |
| 02/13/2003 | WO2003011282A1 Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins |
| 02/13/2003 | US20030032817 Bromination of a 1-ol-gonane-7-one derivative with a source of electrophilic bromine in an etheral solvent, a chlorinated solvent, and acetonitrile |
| 02/13/2003 | CA2448235A1 Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins |
| 02/12/2003 | EP0863906B1 Heterocyclic dioxethane substrates, process for their preparation and their use |
| 02/05/2003 | EP0988311A4 Betulinol derivatives |
| 02/05/2003 | CN1100541C Therapeutic uses and delivery systems of dehydroepiandrosterone |
| 02/04/2003 | US6514956 For treating diseases associated with progestogen dependence and for fertility control, abortion or contraception and for anticancer use |
| 02/04/2003 | CA2057528C Low estrogen oral contraceptives |
| 01/30/2003 | US20030022874 New 17-halogenated 19-nor steroids, preparation process and intermediates, use as medicaments and the pharmaceutical compositions containing them |
| 01/28/2003 | US6512130 Mifepristone analogue, process for the preparation thereof and use thereof |
| 01/28/2003 | CA2094300C Steroid derivatives for the treatment of prostatic hypertrophy, their preparation and uses |
| 01/23/2003 | WO2001005805A9 Novel c-19-halogen-substituted, 5-substituted, 5-substituted or 6,10 carbocyclically condensed steroids of the androst-9(11)-ene-series, methods for the production and use thereof |
| 01/22/2003 | EP1222459A4 Crystallographic structure of the androgen receptor ligand binding domain |
| 01/16/2003 | WO2003004515A1 Process for production of estradiol derivatives, intermediates used in the process and process for production thereof |
| 01/15/2003 | EP1275379A2 Basic granulate comprising (7 alpha, 17 alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one |
| 01/15/2003 | EP1063998B1 Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor |
| 01/15/2003 | EP0754178B1 Novel functionalized hydrophilic acridinium esters |
| 01/15/2003 | EP0595796B1 Method of treatment of androgen-related diseases |
| 01/08/2003 | EP1273590A2 Estra- 1,3,5(10)-triene Derivatives, Methods of Preparing Such Compounds and Pharmaceutical Compositions Containing Them |
| 01/08/2003 | EP1272853A2 Methods for identifying and using amyloid-inhibitory compounds |
| 01/08/2003 | EP1272505A1 8beta-substituted-11beta-pentyl- and 11beta-hexyl-estra-1,3,5(10)-triene derivatives |
| 01/08/2003 | EP1272504A1 8beta-hydrocarbyl-substituted estratrienes for use as selective estrogens |
| 01/08/2003 | EP1272196A2 Methods of making the 4-n-butylcyclohexanoic and the undecanoic acid esters of (7 alpha,11 beta)-dimethyl-17 beta-hydroxy-4-estren-3-one and their medical use |
| 01/08/2003 | EP1272195A1 Use of fulvestrant in the treatment of resistant breast cancer |
| 01/07/2003 | US6503895 Antigestagenically active steroids with a fluorinated 17α-alkyl chain |
| 01/07/2003 | CA2142303C Process for the production of 1-methyl-3-keto- steroids |
| 01/03/2003 | WO2003000271A2 System and method for the large scale labeling of compounds with radiohalogens |
| 01/02/2003 | US20030004333 Contacting chemical intermediate with sulfuric acid |
| 01/02/2003 | US20030004321 Glycosylated analogs of fusidic acid |
| 01/02/2003 | EP1267885A1 Male contraceptive formulation comprising norethisterone |
| 01/02/2003 | EP0980383B1 Pharmaceutically acceptable salts of 3-hydroxy-estr-5(10)-en-17-one 3-sulphate active as estrogens |
| 01/02/2003 | EP0980382B1 Estrogenic 19-norandrost-17-one derivatives with an aromatic b-ring |
| 12/26/2002 | US20020197341 Physiologically synergistic mixtures of pomegranate extracts and methods of use thereof |
| 12/25/2002 | CN1096861C Method of treating androgenic alopecia with 5-alpha reductase inhibitors |
| 12/24/2002 | US6498153 Extended release growth promoting two component composition |
| 12/24/2002 | US6497987 Photosensitive lithocholate derivative and chemically amplified photoresist composition containing the same |
| 12/19/2002 | WO2002101014A2 A process for making estra-4,9(10)-diene steroids |
| 12/19/2002 | WO2002100881A1 Process for the synthesis of oxandrolone |
| 12/19/2002 | WO2002100880A1 Method for preparing oestrogen derivatives |
| 12/19/2002 | WO2002100877A1 Novel 2-alkoxyestradiol analogs with antiproliferative and antimitotic activity |
| 12/19/2002 | US20020193359 Androgen as a male contraceptive and non-contraceptive androgen replacement |
| 12/19/2002 | US20020193357 Liver X receptor agonists |
| 12/18/2002 | EP1266649A1 New derivatives of 7-oxo-dhea and cosmetic use |
| 12/17/2002 | US6495134 Inoculating wood containing chromated copper arsenate (cca) with a fungal inoculum comprising cca-tolerant fungus, lignocellulosic substrate and nutrient supplement to produce biomass; aerating, hydrating to remediate cca |
| 12/12/2002 | WO2002098511A1 Compositions comprising oestrone-3-0-sulphamate and trail (tnf-related apoptosis inducing ligand) |
| 12/12/2002 | US20020187973 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol |
| 12/12/2002 | US20020187970 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-DIOL |
| 12/12/2002 | US20020187969 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol |
| 12/12/2002 | US20020187968 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-DIOL |
| 12/12/2002 | US20020187967 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol |
| 12/12/2002 | US20020187966 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol |
| 12/12/2002 | US20020187965 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol |
| 12/12/2002 | US20020187964 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol |
| 12/12/2002 | US20020187963 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol |
| 12/12/2002 | US20020187962 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol |
| 12/11/2002 | EP1264833A2 1,2-Phenylenediboronic acid reagents and complexes |
| 12/11/2002 | EP1263770A1 6-oxygenated steroidal estrogens with aromatic a and b rings |
| 12/10/2002 | CA2084313C Process for the production of 10beta-h-steroids |
| 12/05/2002 | US20020183532 Bioavailable prodrugs of androgenic steroids and related method |
| 12/05/2002 | US20020182712 Fungal degradation and bioremediation system for cca-treated wood |
| 12/04/2002 | EP0917534B1 6,7-oxygenated steroids and uses related thereto |
| 12/04/2002 | CA2386600A1 1,2-phenylenediboronic acid reagents and complexes |
| 12/03/2002 | US6489313 Improving the memory of a mammal with impaired memory due to aging, wherein said mammal has no diagnosed disease or disorder known to impair memory by administering delta 5-androstene-3 beta-ol-7,17-dione and 3 beta esters thereof |
| 11/28/2002 | WO2002094849A2 Process for the production of 6, 7 - dihydroxy steroid compounds by allylic oxidation of steroid - 5 - ene compounds to steroid - 5 - ene - 7 - one compounds followed by hydroboration and oxidation and intermediates of this process |
| 11/28/2002 | WO2002094379A1 Use and compositions of antiprogestins for treatment of prostate diseases |
| 11/28/2002 | WO2002094303A1 Pomegranate products useful in improving health and methods of use thereof |
| 11/28/2002 | US20020177150 Nucleoside composition for use as tool in human therapeutics and diagnositcs |
| 11/28/2002 | CA2447780A1 Process for the production of 6, 7 - dihydroxy steroid compounds by allylic oxidation of steroid - 5 - ene compounds to steroid - 5 - ene - 7 - one compounds followed by hydroboration and oxidation and intermediates of this process |
| 11/21/2002 | WO2002092618A1 17 alpha-hydroxy-4-androstene-3-one and the 14, 15-methylene-derivatives thereof |
| 11/21/2002 | US20020173499 Estrogen replacement therapy |
| 11/20/2002 | EP0547151B1 Treatment process for promoting weight loss employing a substituted delta 5-androstene |
| 11/14/2002 | WO2002090375A2 Liver x receptor agonists |
| 11/14/2002 | WO2001035106A3 Methods for identifying and using amyloid-inhibitory compounds |
| 11/14/2002 | US20020169152 Methods for treating stress disorders using glucocorticoid receptor-specific antagonists |
| 11/14/2002 | US20020169151 Administering to a mammal,in the absence of estrogen or an agonist, an amount of progesterone or an agonist effective to decrease vascular smooth muscle cell proliferation in the mammal |
| 11/13/2002 | EP1163257B1 Method for producing 4,4-dimethyl-3beta-hydroxypregna-8,14-diene-21-carboxylic acid esters and intermediate products obtained by said method |
| 11/07/2002 | US20020165212 Antiproliferative agent; wound healing agents; antiinflammatory agents |
| 11/05/2002 | US6476012 For therapy of symptomology associated with menopause |
| 10/31/2002 | US20020157939 Subjecting a polyhydric alcohol compound having protected hydroxy group(s) to microwave irradiation in presence of basic compound or acid to deprotect the protecting groups of hydroxy group of polyhydric alcohol compound |
| 10/30/2002 | EP1251856A1 Method of increasing alertness by administration of a vomeropherin, and vomeropherin-emitting alarm devices |
| 10/29/2002 | CA2156493C Method of preventing or inhibiting fertilization |
| 10/24/2002 | US20020156303 Solvent extraction; filtration |
| 10/24/2002 | US20020156060 B-ring estratriene diols |